1. Stocks
  2. InMed Pharmaceuticals Inc
  3. Swot
swot-logo

InMed Pharmaceuticals Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

InMed Pharmaceuticals Inc has 9 Strengths, 22 Weaknesses, 2 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Significant (over 30%) distance from 52 week high

Rising Net Cash Flow and Cash from Operating activity

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Relative Outperformance versus Industry over 1 Week

Companies with Low Debt

Increasing profits every quarter for the past 3 quarters

Stock with Low PE (PE < = 10)

Volume Shockers

Negative Breakdown Third Support (LTP < S3)

Stocks with Quarter Change % less than Industry

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score

Lowest Momentum Scores (Technical Scores)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Inefficient use of assets to generate profits - ROA declining in the last 2 years

Highest fall from 52 Week High

Biggest Price Losers from Open

High volume, top losers

Top Losers

Near 52 Week Low

Negative Breakdown First Support (LTP < S1)

Negative Breakdown Second Support (LTP < S2)

Negative Breakdown third support (LTP < S3)

Degrowth in Quarterly Revenue and Profit in Recent Results(YoY)

Low Piotroski Score : Companies with weak financials

Book Value Per Share deteriorating for last 2 years

Weak performer : Stock lost more than 20% in 1 month

Weak Momentum: Price below Short, Medium and Long Term Averages

Near 52 Week Low

Top Losers

Stocks Underperforming their Industry Price Change in the Quarter

Companies with Upcoming Results

Institutions increasing their shareholding